EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Septal reduction therapy in obstructive hypertrophic cardiomyopathy: contextualizing outcomes in an era of cardiac myosin inhibition

Anirudh Govind iD

European Heart Journal Open · 18.05.2026 · 6 (3)

DOI: 10.1093/ehjopen/oeag087 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Heart Journal Open, online erschienen am 22.05.2026. Verfasst von Anirudh Govind. Beteiligte Einrichtung: Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Dhanvantri Nagar, Pondicherry 605006, India. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Dhanvantri Nagar, Pondicherry 605006, India.

ORCID-Profile: Anirudh Govind

Zitieren

APA

Govind, A. (2026). Septal reduction therapy in obstructive hypertrophic cardiomyopathy: contextualizing outcomes in an era of cardiac myosin inhibition. European Heart Journal Open, 6(3). https://doi.org/10.1093/ehjopen/oeag087

Vancouver

Govind A. Septal reduction therapy in obstructive hypertrophic cardiomyopathy: contextualizing outcomes in an era of cardiac myosin inhibition. European Heart Journal Open. 2026;6(3). doi:10.1093/ehjopen/oeag087

BibTeX
@article{Govind2026,
  author = {Govind, Anirudh},
  title = {Septal reduction therapy in obstructive hypertrophic cardiomyopathy: contextualizing outcomes in an era of cardiac myosin inhibition},
  journal = {European Heart Journal Open},
  year = {2026},
  volume = {6},
  number = {3},
  doi = {10.1093/ehjopen/oeag087}
}
Kostenlos starten →